PRMT7 and non-small cell lung carcinoma: IHC analysis of the resulting tumors showed a concomitant decrease in SOX9 protein levels (Fig. 5i), supporting a model wherein PRMT7 functions as an oncogenic driver by sustaining SOX9 protein expression to promote NSCLC progression.